{"name":"BioNTech Cell & Gene Therapies GmbH","slug":"biontech-cell-gene-therapies-gmbh","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQSDBXZ243SnRELU9tTG5VZTBBaUFIQkVwVmJEYW42OGc5emVxOWVhSGlZcng5U1RDZE5IWUM5YUdYRE1VSDBpVFZxTW5iNUF0X29DSUlDa3RBaHpKRmhwODNuU1hlRmEyQzNDLU9VUlVYN29vb3dTZFl1T21FU2FWNXpGZklzS2hZQXNoV21KczXSAZYBQVVfeXFMTmdVSG5xdU5Qa2JKdFpoQWYyaHhkUkxfM1FUdmljWjc5Z2VZYkxxRzhsa0VmZWZXc2h1UWY4MFFibXlwbXplT0VBS2dITk5ya1oxVlRwN3JJUF9fOFkwQlZ5eHB1NmNwRWZQV0NvMVlmSDZka3laZlZTMjNaN1FXdWxiU0hUSC1XckpWb09qRGNVSDI3UXdR?oc=5","date":"2026-01-17","type":"pipeline","source":"BioInformant","summary":"CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide - BioInformant","headline":"CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidEFVX3lxTE1iTEw4UmJiSHg0bFJFSmg4SkRtZ3VxczVsUTQxWHJsMmt5aUplUTNyaDVuLTdmbENFN0JxWnlCQkdPUG42UTdqcjBVRVo1SUEydElvRFN6Wjd4a2s1d1lzUjdzSGNIemlsU0FtX2d4Z0RUeGxB?oc=5","date":"2025-12-18","type":"pipeline","source":"CureVac","summary":"CureVac is now part of the BioNTech Group - CureVac","headline":"CureVac is now part of the BioNTech Group","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxNM2NTMWVDSDcxZmVvTklTZmhpU3JUel9ablNETnMycDBYYWdRdVNGeWpleVl5eGJYUDFJZnpEZ0dVYi1pOHNfZTZPUTNzcFBwOFMzcmV0bF9YeTVGRnhHRERZZFFUQ3FnNlF2SVgzUjVFamhkRy1LdU5SdkxrUjVFV3hzSWh6WTVLYUNvVkxR?oc=5","date":"2025-07-21","type":"pipeline","source":"Frontiers","summary":"Unraveling the potential: mRNA therapeutics in oncology - Frontiers","headline":"Unraveling the potential: mRNA therapeutics in oncology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxPUXB6TklpbmRxMkE2enI1WTJzc3FBZy00MEVFWDU0LS03cmo3Y0x3ZkZWLWYxdHJ0TDM5WWlyZ2JoTEdQa0dXZHRZQ3UwWFRzZTRhU3B4ckVqcGVpTmNzaDZQZmw1ODdTcldOZ05GTkhsZVJZVjdiYXpCQUEzNTRzMTZXQUtLbFg5cmd1QzQ1ZWEzcDJMV0lKUHRXWWJvS01UUWdJ?oc=5","date":"2025-06-24","type":"pipeline","source":"PharmTech.com","summary":"Looking Beyond mRNA-based COVID-19 Vaccines to Innovative Therapeutics - PharmTech.com","headline":"Looking Beyond mRNA-based COVID-19 Vaccines to Innovative Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxQVnpIbWMxdzdpeE0tT1BvaUp5b3F0ZHM1VjNZcXNhSExVandfaG53TU5Ld2hOdVhPTTVSWHlPT1ppYWNORVJCQ3RudFlaZFhaNUgybzluTlFNaC1ITGFuTjhuRHg4bVRyR2cwaFViX0wyVHhfc09sM2NES1NQbUpYMGphR3dubGtW?oc=5","date":"2025-04-21","type":"earnings","source":"Fierce Pharma","summary":"The top 20 pharma companies by 2024 revenue - Fierce Pharma","headline":"The top 20 pharma companies by 2024 revenue","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5MNFhIY0I3aVBsT0U5MUpydG85SUI2MnFKc0FpRXV2SjQ1VktoY09Ec2NUMERUMW1aTjA1M3BBUmNBRnNST1J4eXRvbHZDb3ZnOFNEY3JTWXRjZGpkelVj?oc=5","date":"2025-04-09","type":"trial","source":"nature.com","summary":"Autologous T cell therapy for PRAME+ advanced solid tumors in HLA-A*02+ patients: a phase 1 trial | Nature Medicine - nature.com","headline":"Autologous T cell therapy for PRAME+ advanced solid tumors in HLA-A*02+ patients: a phase 1 trial | Nature Medicine","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8wFBVV95cUxPMnhpMVAxUVYxT3kxYmZhQWp5Q1pKbElfMEQwa2tKT1NMVjVYdEdNT19zYWZaUDY3LXVObXhQUTJ0MmFsdjFzeXBVcklhTEc4RmNxWnpFZU1FV0toU2NDVlh5OG5uU3hLTWF5LTZDYnRCTDFsUmlYSlY5NktYMVptMDZRUDRxMVgwamZKa3YzTHRXQTJOUXRjSWZfMS1EZ0tUbUlUSzZzb3NlbUZ1RGNoX0ZjaWtkWDdBbk9uUUg4bUJyYTlhaF9ESlhsOU52ZExfcXZqczB1c0FMeUl3dy0tdzF1OWZhTW9ZcU9zemJyakhneTA?oc=5","date":"2025-02-25","type":"pipeline","source":"PR Newswire","summary":"Global Advanced Therapy Medicinal Products Market to Grow Immensely at a CAGR of ~14% by 2032 | DelveInsight - PR Newswire","headline":"Global Advanced Therapy Medicinal Products Market to Grow Immensely at a CAGR of ~14% by 2032 | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxOVjlSZ29ZTFlReHRaYzhGLXRneUVXQ3RtZ1ZpeC10VkQ5aTAyamN4SFFES0FuTjJwVzFUeXdpTjFULW11UmNabjVYanBLcGo3bzhSdExxNnFxMk13YzFFSERMdk9Zc0RlT2JKYmN5NXlMeVc1RzFUZEkwY0R6bWhDbXNtY2hPOFVDTXd6ajJLbWdMNDZsbC11WkRaNA?oc=5","date":"2024-07-18","type":"pipeline","source":"Allied Market Research","summary":"Viral Vectors and Plasmid DNA Manufacturing Market Forecast - 2033 - Allied Market Research","headline":"Viral Vectors and Plasmid DNA Manufacturing Market Forecast - 2033","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTFB1N2d4NnYwN0JiU181Tm9vV0dUM1c1NWVMUHNCdlZFVmRSZXpmRFp3TnBQUVJXYnFYV1VlNVBIZXU0TzY4bE5BNTd4NGpIT21aYlZHMy1qSW1HWDFH?oc=5","date":"2024-07-15","type":"pipeline","source":"BioSpace","summary":"Layoff Tracker: BioNTech Will Close Singapore Plant, Affecting 85 Employees - BioSpace","headline":"Layoff Tracker: BioNTech Will Close Singapore Plant, Affecting 85 Employees","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxQV1dUd1R1QTF5YVhwaTdsd3A1XzNDU2JDU01rWExsUnE0bnpkSnFHSF9WNnBxbm9EQ2I3NGowdzBYR0NyOWt5ZmEwa2owVWg5TWU5MkxkTXhRcWo2ZUh2LVAyMGtqeXB5R28wUDZNUzBoaXdQVmp3dmd0Q1hlclU5bERtQllzMDZDOTlZN2R3X1FHWlQ1WTFXNGVMb0F0OGxwSjVoQ0s5eWdCVnB0U1E?oc=5","date":"2021-02-12","type":"pipeline","source":"Pharmaceutical Technology","summary":"BioNTech’s COVID-19 Vaccine Manufacturing Facility, Marburg - Pharmaceutical Technology","headline":"BioNTech’s COVID-19 Vaccine Manufacturing Facility, Marburg","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxQRDNGdFJ6engwWl9NTnhXWXAybUxFWUdPeWs5azV1Zi05MUVVQ1hENWJ6WWVCYjdZS1czV3NBTVE3R0VoN1N1Z3FCcnJUcmVBODExZ3lRbC1zcUlJYl9vUWFYanFlTWxQZ0F0Wl9ielJ6VmhoSWc0WFd4VUZPT19Qdlg0OWxYUFBDaFlQTTJlQ3hJMFplOFFTdEw0YURDNU9DZDZ4MlljUFMwWlZaUlh4WnoxQ2dWaTlUcVlZ?oc=5","date":"2020-09-23","type":"pipeline","source":"BioProcess International","summary":"From flu jabs, to mAbs, to COVID collabs: BioNTech nabs Novartis plant and labs - BioProcess International","headline":"From flu jabs, to mAbs, to COVID collabs: BioNTech nabs Novartis plant and labs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxOVkJCVlc4aUJIaGIyQzFBeGdZN2JNdGNrdmx6b2VrMURSQWtOUElyY1o4d2hCaXZ3TTVlZzJDbmo2LW5xbC1DSnZhMS05dm5OT2NkRE1vNmFNTWFUZ3pnMU9aZGsyQ0trUWNOV0VSbTFFRENJSjFoY00xdEpSRjZZYUhJZl8?oc=5","date":"2020-09-22","type":"regulatory","source":"CHEManager","summary":"BioNTech Acquiring Novartis’ Marburg Site - CHEManager","headline":"BioNTech Acquiring Novartis’ Marburg Site","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}